Merck & Co., Inc. financial data

Symbol
MRK on NYSE
Location
126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 % +9.89%
Quick Ratio 23.4 % -2.58%
Return On Equity 38.9 % +33.1%
Return On Assets 15.9 % +44.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.48B shares -1.88%
Entity Public Float 314B USD +7.13%
Common Stock, Value, Issued 1.79B USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.5B shares -1.54%
Weighted Average Number of Shares Outstanding, Diluted 2.5B shares -1.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 64.2B USD +1.68%
Research and Development Expense 16.5B USD -28.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 21.8B USD +59%
Income Tax Expense (Benefit) 2.77B USD +78.1%
Net Income (Loss) Attributable to Parent 19B USD +56.7%
Earnings Per Share, Basic 7 USD/shares +58%
Earnings Per Share, Diluted 7 USD/shares +58.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.2B USD +24.5%
Marketable Securities, Current 45M USD
Accounts Receivable, after Allowance for Credit Loss, Current 12.1B USD +6.49%
Inventory, Net 6.44B USD +3.2%
Other Assets, Current 10.8B USD +32.4%
Assets, Current 47.6B USD +17.8%
Property, Plant and Equipment, Net 25.6B USD +9.35%
Operating Lease, Right-of-Use Asset 1.37B USD -4.66%
Intangible Assets, Net (Excluding Goodwill) 15.3B USD -9.98%
Goodwill 21.6B USD -0.51%
Other Assets, Noncurrent 18.3B USD +26.9%
Assets 130B USD +10.2%
Accounts Payable, Current 4.15B USD +15.6%
Liabilities, Current 28.6B USD -3.24%
Deferred Income Tax Liabilities, Net 1.38B USD +59.8%
Operating Lease, Liability, Noncurrent 877M USD -5.5%
Other Liabilities, Noncurrent 7.66B USD +1.61%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.2B USD +3.15%
Retained Earnings (Accumulated Deficit) 72.2B USD +17.7%
Stockholders' Equity Attributable to Parent 51.9B USD +16.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 51.9B USD +16.5%
Liabilities and Equity 130B USD +10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.5B USD -19.1%
Net Cash Provided by (Used in) Financing Activities -5.76B USD -105%
Net Cash Provided by (Used in) Investing Activities -1.49B USD -8.07%
Common Stock, Shares Authorized 6.5B shares 0%
Common Stock, Shares, Issued 3.58B shares 0%
Common Stock, Par or Stated Value Per Share 0.5 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.59B USD -270%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.3B USD +24.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 233M USD +7.37%
Deferred Tax Assets, Valuation Allowance 710M USD +8.23%
Deferred Tax Assets, Gross 5.98B USD +26.9%
Operating Lease, Liability 1.16B USD -4.45%
Depreciation 502M USD -1.76%
Payments to Acquire Property, Plant, and Equipment 1.33B USD +54.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 19.2B USD +64.2%
Lessee, Operating Lease, Liability, to be Paid 1.52B USD +9.5%
Property, Plant and Equipment, Gross 42.9B USD +3.91%
Operating Lease, Liability, Current 282M USD -1.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 292M USD +8.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 329M USD +1.23%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -186M USD -265%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 362M USD +106%
Lessee, Operating Lease, Liability, to be Paid, Year Three 235M USD +5.86%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 2.26B USD -5.16%
Lessee, Operating Lease, Liability, to be Paid, Year Four 146M USD +5.04%
Deferred Tax Assets, Net of Valuation Allowance 5.27B USD +30%
Interest Expense 1.21B USD +25.6%